Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:50 UTC
Update Date2022-03-07 02:51:42 UTC
HMDB IDHMDB0014662
Secondary Accession Numbers
  • HMDB14662
Metabolite Identification
Common NameCarteolol
DescriptionCarteolol is only found in individuals that have used or taken this drug. It is a beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. [PubChem]The primary mechanism of the ocular hypotensive action of carteolol in reducing intraocular pressure is most likely a decrease in aqueous humor production. This process is initiated by the non-selective beta1 and beta2 adrenergic receptor blockade.
Structure
Data?1582753205
Synonyms
ValueSource
CarteololumChEBI
Hydrochloride, carteololHMDB
Carteolol monohydrochlorideHMDB
Carteolol hydrochlorideHMDB
Monohydrochloride, carteololHMDB
Chemical FormulaC16H24N2O3
Average Molecular Weight292.3734
Monoisotopic Molecular Weight292.178692644
IUPAC Name5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydroquinolin-2-one
Traditional Namecarteolol
CAS Registry Number51781-06-7
SMILES
CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2
InChI Identifier
InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)
InChI KeyLWAFSWPYPHEXKX-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hydroquinolines. These are derivatives of quinoline in which in which at least one double bond in the quinoline moiety are reduced by adding two hydrogen atoms.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassQuinolines and derivatives
Sub ClassHydroquinolines
Direct ParentHydroquinolines
Alternative Parents
Substituents
  • Dihydroquinoline
  • Alkyl aryl ether
  • Benzenoid
  • Cyclic carboximidic acid
  • 1,2-aminoalcohol
  • Secondary alcohol
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Secondary amine
  • Ether
  • Secondary aliphatic amine
  • Azacycle
  • Organopnictogen compound
  • Alcohol
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.42 g/LNot Available
LogP1.1Not Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.42 g/LALOGPS
logP1.05ALOGPS
logP1.42ChemAxon
logS-2.8ALOGPS
pKa (Strongest Acidic)13.41ChemAxon
pKa (Strongest Basic)9.76ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area70.59 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity83.14 m³·mol⁻¹ChemAxon
Polarizability32.79 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+169.45131661259
DarkChem[M-H]-165.50131661259
DeepCCS[M+H]+166.40530932474
DeepCCS[M-H]-164.04730932474
DeepCCS[M-2H]-196.94230932474
DeepCCS[M+Na]+172.49930932474
AllCCS[M+H]+170.132859911
AllCCS[M+H-H2O]+166.932859911
AllCCS[M+NH4]+173.032859911
AllCCS[M+Na]+173.832859911
AllCCS[M-H]-174.032859911
AllCCS[M+Na-2H]-174.432859911
AllCCS[M+HCOO]-175.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
CarteololCC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N23720.2Standard polar33892256
CarteololCC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N22497.5Standard non polar33892256
CarteololCC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N22588.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Carteolol,1TMS,isomer #1CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C2538.7Semi standard non polar33892256
Carteolol,1TMS,isomer #2CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2)[Si](C)(C)C2703.9Semi standard non polar33892256
Carteolol,1TMS,isomer #3CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C2399.8Semi standard non polar33892256
Carteolol,2TMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C)[Si](C)(C)C2706.5Semi standard non polar33892256
Carteolol,2TMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C)[Si](C)(C)C2741.8Standard non polar33892256
Carteolol,2TMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C)[Si](C)(C)C3356.8Standard polar33892256
Carteolol,2TMS,isomer #2CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)O[Si](C)(C)C2341.8Semi standard non polar33892256
Carteolol,2TMS,isomer #2CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)O[Si](C)(C)C2557.6Standard non polar33892256
Carteolol,2TMS,isomer #2CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)O[Si](C)(C)C2912.4Standard polar33892256
Carteolol,2TMS,isomer #3CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)[Si](C)(C)C2500.6Semi standard non polar33892256
Carteolol,2TMS,isomer #3CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)[Si](C)(C)C2698.3Standard non polar33892256
Carteolol,2TMS,isomer #3CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)[Si](C)(C)C3037.4Standard polar33892256
Carteolol,3TMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C2568.8Semi standard non polar33892256
Carteolol,3TMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C2730.4Standard non polar33892256
Carteolol,3TMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C2843.3Standard polar33892256
Carteolol,1TBDMS,isomer #1CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C(C)(C)C2772.8Semi standard non polar33892256
Carteolol,1TBDMS,isomer #2CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2)[Si](C)(C)C(C)(C)C2950.1Semi standard non polar33892256
Carteolol,1TBDMS,isomer #3CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C2654.6Semi standard non polar33892256
Carteolol,2TBDMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3181.8Semi standard non polar33892256
Carteolol,2TBDMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3194.5Standard non polar33892256
Carteolol,2TBDMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3434.1Standard polar33892256
Carteolol,2TBDMS,isomer #2CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2787.1Semi standard non polar33892256
Carteolol,2TBDMS,isomer #2CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2996.4Standard non polar33892256
Carteolol,2TBDMS,isomer #2CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3053.3Standard polar33892256
Carteolol,2TBDMS,isomer #3CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3029.0Semi standard non polar33892256
Carteolol,2TBDMS,isomer #3CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3125.4Standard non polar33892256
Carteolol,2TBDMS,isomer #3CC(C)(C)N(CC(O)COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3139.9Standard polar33892256
Carteolol,3TBDMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3269.2Semi standard non polar33892256
Carteolol,3TBDMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3351.4Standard non polar33892256
Carteolol,3TBDMS,isomer #1CC(C)(C)N(CC(COC1=CC=CC2=C1CCC(=O)N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3056.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Carteolol GC-MS (Non-derivatized) - 70eV, Positivesplash10-06z0-9740000000-0b5ab7905026b4d1b8e02017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Carteolol GC-MS (1 TMS) - 70eV, Positivesplash10-00ei-9174000000-c2dec5c3c1c4cd91a5902017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Carteolol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 10V, Positive-QTOFsplash10-0006-1290000000-146882f3ae5a571c8d6d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 20V, Positive-QTOFsplash10-000i-6690000000-936db670e7e2bee8b0572016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 40V, Positive-QTOFsplash10-00ds-9700000000-7905914cd5a5de3da04f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 10V, Negative-QTOFsplash10-0006-1690000000-609050e71156510420f02016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 20V, Negative-QTOFsplash10-03dl-1900000000-c56c1b1cc8e1ca5d10b62016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 40V, Negative-QTOFsplash10-0006-6900000000-b28a89fc1f36ea8434252016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 10V, Positive-QTOFsplash10-0006-0090000000-75cd5cfb725bb644735f2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 20V, Positive-QTOFsplash10-02bu-2390000000-1f80e682ad20e7f3f9f72021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 40V, Positive-QTOFsplash10-0a4i-9400000000-a3900f5b32740668f2572021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 10V, Negative-QTOFsplash10-0006-0390000000-423a88b9dbb47af0573e2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 20V, Negative-QTOFsplash10-03di-1910000000-a9e99c1ea5d66cae18652021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Carteolol 40V, Negative-QTOFsplash10-03dm-1900000000-8e73f5d27804e3688cd32021-09-24Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00521 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00521 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00521
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID2485
KEGG Compound IDC06874
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCarteolol
METLIN IDNot Available
PubChem Compound2583
PDB IDNot Available
ChEBI ID3437
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Trinquand C, Romanet JP, Nordmann JP, Allaire C: [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. J Fr Ophtalmol. 2003 Feb;26(2):131-6. [PubMed:12660585 ]
  2. Kuwahara K, Oizumi N, Fujisawa S, Tanito M, Ohira A: Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro. Cornea. 2005 Mar;24(2):213-20. [PubMed:15725891 ]
  3. El-Kamel A, Al-Dosari H, Al-Jenoobi F: Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. Drug Deliv. 2006 Jan-Feb;13(1):55-9. [PubMed:16401594 ]

Enzymes

General function:
Involved in monooxygenase activity
Specific function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular weight:
55768.94
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
  2. Kudo S, Uchida M, Odomi M: Metabolism of carteolol by cDNA-expressed human cytochrome P450. Eur J Clin Pharmacol. 1997;52(6):479-85. [PubMed:9342584 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Beta-adrenergic receptors mediate the catecholamine- induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity
Gene Name:
ADRB1
Uniprot ID:
P08588
Molecular weight:
51322.1
References
  1. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  2. Bruck H, Poller U, Lussenhop H, Ponicke K, Temme T, Heusch G, Philipp T, Brodde OE: Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):361-8. Epub 2004 Oct 23. [PubMed:15526107 ]
  3. Chidlow G, Melena J, Osborne NN: Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists. Br J Pharmacol. 2000 Jun;130(4):759-66. [PubMed:10864881 ]
  4. Floreani M, Froldi G, Quintieri L, Varani K, Borea PA, Dorigo MT, Dorigo P: In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol. J Pharmacol Exp Ther. 2005 Dec;315(3):1386-95. Epub 2005 Sep 13. [PubMed:16160085 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Beta-adrenergic receptors mediate the catecholamine- induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine
Gene Name:
ADRB2
Uniprot ID:
P07550
Molecular weight:
46458.3
References
  1. Wheeldon NM, McDevitt DG, Lipworth BJ: Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol. Br J Clin Pharmacol. 1992 Apr;33(4):411-6. [PubMed:1349493 ]
  2. Bruck H, Poller U, Lussenhop H, Ponicke K, Temme T, Heusch G, Philipp T, Brodde OE: Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):361-8. Epub 2004 Oct 23. [PubMed:15526107 ]
  3. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]